Medical Disclaimer: This site provides informational comparisons only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before making medication decisions.
Brand names: Xeljanz
Inhibits Janus kinases JAK1 and JAK3, modulating the signalling of interleukins and interferons involved in immune and inflammatory pathways.
9 documented side effects by frequency
No community discussions found for Tofacitinib yet.
24 available comparisons
Dosage Forms
Tablet, Extended-release tablet
Route
Oral